ASH Clinical News ACN_4.5_FULL_ISSUE_DIGITAL - Page 9

The Society Pages

UP FRONT

Remembering Ihor R . Lemischka ( 1953-2017 )

Ihor R . Lemischka , PhD
Ihor R . Lemischka , PhD , a pioneer in the fields of hematopoiesis and pluripotent cell biology , died on December 17 , 2017 .
Dr . Lemischka was born in 1953 to Ukrainian immigrants in Trenton , New Jersey . He earned his PhD at the Massachusetts Institute of Technology , where he studied pseudo-genes and was among the first to determine their origins through RNAmediated insertions . He then spent 21 years at Princeton University , where he successfully isolated hematopoietic stem cells from a fetal liver and constructed their first molecular profiles . Dr . Lemischka established the Stem Cell and Stromal Cell Databases to make this information public to the stem cell research community .
He was appointed director of the Black Family Stem Cell Institute at the Icahn
School of Medicine at Mount Sinai in New York in 2007 , where he remained for the rest of his career . In addition to his achievements in the field of stem cell biology , Dr . Lemischka was known to many as a mentor , fostering the careers of the next generation of researchers .
Dr . Lemischka served on numerous National Institutes of Health ( NIH ) review panels and was an advisory board member for the New York Stem Cell Foundation , Harvard Stem Cell Institute , and University of California Los Angeles Program in Regenerative Medicine .
He is survived by his wife and long-time collaborator , Kateri A . Moore , DVM , also of the Icahn School of Medicine at Mount Sinai .
Source : Ivanova N , Pereira CF , Lee DF . Ihor R . Lemischka ( 1953 – 2017 ). Cell Stem Cell . 2018 ; 22:16-7 .

Remembering Günter Blobel ( 1936-2018 )

Nobel laureate Günter Blobel , MD , PhD , a molecular biologist , died of cancer on February 18 , 2018 . He spent most of his working life at Rockefeller University in New York . With funding from the NIH and the Howard Hughes Medical Institute , his 30 years of investigation culminated in a discovery for which he won the 1999 Nobel Prize in medicine :
Günter Blobel , Proteins in any living cell have internal signals that direct MD , PhD their transport within the cell and throughout the body . “[ Dr .] Blobel ’ s discovery has had an immense impact on modern cell biological research ,” the Nobel Assembly at the Karolinska
Institute in Stockholm said when announcing the prize . “ Furthermore , knowledge about the topogenic signals has increased our understanding of many medically important mechanisms .”
Dr . Blobel won numerous other awards , including the 1987 Louisa Gross Horwitz Prize for biochemistry from Columbia University and the Albert Lasker Basic Medical Research Award in 1993 .
He is survived by his wife Laura Maioglio ; three brothers , Hans , Reiner , and Albrecht ; and two sisters , Sigrid Mack and Ingeborg Cosack .
Source : The New York Times , February 19 , 2018 .
Louis Weiner Named Director of MedStar Georgetown Cancer Institute
MedStar Health appointed Louis M . Weiner , MD , as director of its MedStar Georgetown Cancer Institute . Dr . Weiner will remain director of Georgetown Lombardi Comprehensive Cancer Center , the research engine of the institute . As director of the MedStar Georgetown Cancer Institute , he will lead the development and
Louis M . Weiner , MD coordination of clinical care and research programs spanning prevention , treatment , rehabilitation , survivorship , and end-of-life care across the MedStar Health system .
“ I am honored to have the opportunity to lead this effort ,” Dr . Weiner said in a statement . “ This is an exciting time for the field of cancer therapy , as new treatments are transforming the outlook for patients with this dreaded set of diseases .”
Prior to his appointment at Georgetown Lombardi in 2007 , Dr . Weiner held several leadership positions at Temple University Health System ’ s Fox Chase Cancer Center in Philadelphia . Dr . Weiner ’ s research career has focused on the development of monoclonal antibodies and other
immunotherapy treatments . He serves as chair of the National Cancer Institute ’ s Board of Scientific Counselors and as a member of its Clinical Trials Advisory Committee . In addition , Weiner recently concluded service as a member of the Advisory Panel of the NIH Center for Scientific Research , which administers NIH research grants .
Source : MedStar Health press release , November 20 , 2017 .
Raoul Tibes Leads Perlmutter Cancer Center ’ s Expanded Clinical Leukemia Program
New York University ( NYU ) Langone Health announced that Raoul Tibes , MD , PhD , associate professor of hematology and medical oncology at NYU School of Medicine , will lead efforts to
Raoul Tibes , MD , PhD expand the clinical and investigative leukemia programs at
its Perlmutter Cancer Center . Dr . Tibes joined Perlmutter from the Mayo Clinic in Arizona , where he served as an assistant professor of medicine and clinical consultant .
In his new position , Dr . Tibes will lead the clinical application of genomic discoveries and advances in targeted therapies for blood cancers , and develop investigator-initiated trials of specific biomarkers for leukemia . He will also work closely with Ahmad Samer Al-Homsi , MD , the director of bone marrow transplantation at Perlmutter .
Source : New York University Langone Health press release , November 29 , 2017 .
Feinstein Institute Researcher Awarded NIH Grant to Study Post- Cancer Fertility
Catherine Benedict , PhD
Catherine Benedict , PhD , a medical research assistant professor at the Feinstein Institute for Medical Research , was awarded a two-year , $ 165,000 grant from the NIH to study how young women who completed cancer treatment make fertility decisions and plan for future families . This project will lead to the development of a decision-making and planning tool to help young survivors evaluate their options for having children after cancer .
“ Even if young women make some fertility plans before undergoing cancer treatment , many are still unclear of how to navigate their options post treatment when they actually want to plan for a family ,” said Dr . Benedict . “ They are often
ASHClinicalNews . org ASH Clinical News
7
UP FRONT The Society Pages Remembering Ihor R. Lemischka Ihor R. Lemischka, PhD, a pioneer in the fields of hematopoiesis and pluripotent cell biology, died on December 17, 2017. Dr. Lemischka was born in 1953 to Ukrainian immigrants in Trenton, New Jersey. He earned his PhD at the Massachusetts Institute of Technology, where he studied pseudo-genes and was among the first to determine their origins through RNA- mediated insertions. He then spent 21 years at Princeton Ihor R. Lemischka, PhD University, where he successfully isolated hematopoietic stem cells from a fetal liver and constructed their first molecular profiles. Dr. Lemischka established the Stem Cell and Stromal Cell Databases to make this information public to the stem cell research community. He was appointed director of the Black Family Stem Cell Institute at the Icahn School of Medicine at Mount Sinai in New York in 2007, where he remained for the rest of his career. In addition to his achievements in the field of stem cell biology, Dr. Lemischka was known to many as a mentor, fostering the careers of the next generation of researchers. Dr. Lemischka served on numerous National Institutes of Health (NIH) review panels and was an advisory board member for the New York Stem Cell Foundation, Harvard Stem Cell Institute, and University of California Los Angeles Program in Regenerative Medicine. He is survived by his wife and long-time collaborator, Kateri A. Moore, DVM, also of the Icahn School of Medicine at Mount Sinai. Source: Ivanova N, Pereira CF, Lee DF. Ihor R. Lemischka (1953–2017). Cell Stem Cell. 2018;22:16-7. Remembering Günter Blobel Nobel laureate Günter Blobel, MD, PhD, a molecular biolo- gist, died of cancer on February 18, 2018. He spent most of his working life at Rockefeller University in New York. With funding from the NIH and the Howard Hughes Medical Institute, his 30 years of investigation culminated in a dis- covery for which he won the 1999 Nobel Prize in medicine: Proteins in any living cell have internal signals that direct Günter Blobel, MD, PhD their transport within the cell and throughout the body. “[Dr.] Blobel’s discovery has had an immense impact on modern cell biological research,” the Nobel Assembly at the Karolinska Louis Weiner Named Director of MedStar Georgetown Cancer Institute MedStar Health appointed Louis M. Weiner, MD, as director of its MedStar Georgetown Cancer Institute. Dr. Weiner will remain director of Georgetown Lombardi Comprehensive Cancer Center, the research engine of the institute. As director of the MedStar Georgetown Cancer Institute, he will lead the development and Louis M. Weiner, MD coordination of clinical care and research programs spanning prevention, treatment, rehabilitation, survivorship, and end-of-life care across the MedStar Health system. “I am honored to have the opportunity to lead this effort,” Dr. Weiner said in a statement. “This is an exciting time for the field of cancer therapy, as new treatments are transforming the outlook for patients with this dreaded set of diseases.” Prior to his appointment at Georgetown Lombardi in 2007, Dr. Weiner held several lead- ership positions at Temple University Health System’s Fox Chase Cancer Center in Philadelphia. Dr. Weiner’s research career has focused on the development of monoclonal antibodies and other ASHClinicalNews.org (1953-2017) (1936-2018) Institute in Stockholm said when announcing the prize. “Furthermore, knowledge about the topogenic signals has increased our understanding of many medically important mechanisms.” Dr. Blobel won numerous other awards, including the 1987 Louisa Gross Horwitz Prize for biochemistry from Columbia University and the Albert Lasker Basic Medical Research Award in 1993. He is survived by his wife Laura Maioglio; three brothers, Hans, Reiner, and Albrecht; and two sisters, Sigrid Mack and Ingeborg Cosack. Source: The New York Times, February 19, 2018. immunotherapy treatments. He serves as chair of the National Cancer Institute’s Board of Scientific Counselors and as a member of its Clinical Trials Advisory Committee. In addition, Weiner recently concluded service as a member of the Advisory Panel of the NIH Center for Scientific Research, which administers NIH research grants. Source: MedStar Health press release, November 20, 2017. Raoul Tibes Leads Perlmutter Cancer Center’s Expanded Clinical Leukemia Program New York University (NYU) Langone Health announced that Raoul Tibes, MD, PhD, associ- ate professor of hematology and medical oncology at NYU School of Medicine, will lead efforts to Raoul Tibes, MD, PhD expand the clinical and inves- tigative leukemia programs at its Perlmutter Cancer Center. Dr. Tibes joined Perlmutter from the Mayo Clinic in Arizona vW&RR6W'fVB2767FB&fW76 bVF6RB6Ɩ667VFBख2Wr6FG"F&W2vVBFP6Ɩ6Ɩ6FbvV֖2F66fW&W2@Gf6W2F&vWFVBFW&W2f"&B66W'2BFWfVfW7FvF"֖FFVBG&2b7V6f0&&W'2f"WVV֖Rv6v&66VǐvFB6W"Ԇ6BFRF&V7F"`&R'&rG&7FFBW&WGFW"6W&6SWr&VfW'6GvRVF&W72&VV6RfV&W"##rfV7FV7FGWFR&W6V&6W v&FVB䔂w&BF7GVG7BФ66W"fW'FƗG6FW&R&VVF7BBVF6&W6V&6767F@&fW76"BFRfV7FV7FЧGWFRf"VF6&W6V&6v0v&FVBGvזV"CcRw&Bg&FR䔂F7GVGpVrvVv6WFV@6FW&R&VVF7B@66W"G&VFVBRfW'FƗGFV662Bf"gWGW&Pf֖ƖW2F2&V7BvVBFFRFWfVV@bFV66rBrFFVVr7W'ff'2WfVFRFV"F2f"fp6G&VgFW"66W"( WfVbVrvVR6RfW'FƗG2&Vf&RVFW&vr66W"G&VFVB琦&R7FV6V"brFfvFRFV"F07BG&VFVBvVFW7GVǒvBFf"f֖ǒ( 6BG"&VVF7B( FW&RgFV46Ɩ6Ww0p